Quest Diagnostics Inc Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31)
Quest Diagnostics Inc (DGX) reported Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) of $696.00 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-24.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount · last filed 2015-02-24
- Quest Diagnostics Inc stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for the quarter ending 2014-12-31 was -$50.00M.
- Quest Diagnostics Inc stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for the quarter ending 2014-09-30 was -$25.00M, a 104.83% decline year-over-year.
- Quest Diagnostics Inc stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for the quarter ending 2014-06-30 was -$25.00M.
- Quest Diagnostics Inc stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for the quarter ending 2014-03-31 was $796.00M, a 0.87% decline year-over-year.
- Quest Diagnostics Inc stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for fiscal 2014 was $696.00M, a 15.94% decline from fiscal 2013.
- Quest Diagnostics Inc stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for fiscal 2013 was $828.00M, a 4.28% decline from fiscal 2012.
- Quest Diagnostics Inc stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for fiscal 2012 was $865.00M.
| Period end | Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 1 month | Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 3 month | Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 6 month | Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 9 month | Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 12 month |
|---|---|---|---|---|---|
| 2014-12-31 | -$50.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$75.00M derived: sum of 2 quarters · filed 2015-02-24 | -$100.00M derived: sum of 3 quarters · filed 2015-02-24 | $696.00M 10-K · filed 2015-02-24 | |
| 2014-09-30 | -$25.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$50.00M derived: sum of 2 quarters · filed 2014-10-30 | $746.00M 10-Q · filed 2014-10-30 | $703.00M derived: sum of 4 quarters · filed 2014-10-30 | |
| 2014-06-30 | -$25.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $771.00M 10-Q · filed 2014-07-31 | $728.00M derived: sum of 3 quarters · filed 2014-07-31 | $1.25B derived: sum of 4 quarters · filed 2014-07-31 | |
| 2014-03-31 | $796.00M 10-Q · filed 2014-05-01 | $753.00M derived: sum of 2 quarters · filed 2014-05-01 | $1.27B derived: sum of 3 quarters · filed 2014-05-01 | $821.00M derived: sum of 4 quarters · filed 2014-05-01 | |
| 2013-12-31 | -$43.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $475.00M derived: sum of 2 quarters · filed 2014-02-18 | $25.00M derived: sum of 3 quarters · filed 2014-02-18 | $828.00M 10-K · filed 2014-02-18 | |
| 2013-09-30 | $518.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-24 | $68.00M derived: sum of 2 quarters · filed 2013-10-24 | $871.00M 10-Q · filed 2013-10-24 | $821.00M derived: sum of 4 quarters · filed 2013-10-24 | |
| 2013-08-31 | $1.30B 10-K · filed 2015-02-24 | ||||
| 2013-06-30 | -$450.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $353.00M 10-Q · filed 2013-07-25 | $303.00M derived: sum of 3 quarters · filed 2013-07-25 | $253.00M derived: sum of 4 quarters · filed 2013-07-25 | |
| 2013-03-31 | $803.00M 10-Q · filed 2013-04-24 | $753.00M derived: sum of 2 quarters · filed 2013-04-24 | $703.00M derived: sum of 3 quarters · filed 2013-04-24 | ||
| 2012-12-31 | -$50.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$100.00M derived: sum of 2 quarters · filed 2013-02-27 | $865.00M 10-K · filed 2013-02-27 | ||
| 2012-09-30 | -$50.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | $915.00M 10-Q · filed 2012-10-24 | |||
| 2012-06-30 | $965.00M 10-Q · filed 2012-07-26 | ||||
| 2012-01-31 | $1.10B 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |